1.30

3.70% -0.05

Standard Biotools Inc (LAB)

Overview News Price History Option Chain Financials Discussions Forecast

Standard Biotools Inc stock is traded at $1.30, with a volume of 1.06M. It is down -3.70% in the last 24 hours and down -30.85% over the past month. Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Previous Close:

$1.35

Open:

$1.38

24h Volume:

1.06M

Relative Volume:

0.61

Market Cap:

$483.94M

Revenue:

$106.34M

Net Income/Loss:

$-74.66M

P/E Ratio:

-1.3684

EPS:

-0.95

Net Cash Flow:

$-46.12M

1W Performance:

-7.80%

1M Performance:

-30.85%

6M Performance:

-32.99%

1Y Performance:

-45.83%

1-Day Range:

$1.30

$1.39

1-Week Range:

$1.30

$1.51

52-Week Range:

$1.1725

$3.04

Standard Biotools Inc Stock (LAB) Company Profile

Name

Standard Biotools Inc

Sector

Healthcare (1169)

Industry

Medical Devices (154)

Phone

(650) 266-6000

Address

2 TOWER PLACE, SOUTH SAN FRANCISCO

Employee

539

Twitter

Next Earnings Date

2025-02-14

Latest SEC Filings

LAB's Discussions on Twitter

Compare LAB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LAB Standard Biotools Inc	1.30	483.94M	106.34M	-74.66M	-46.12M	-0.95
ABT Abbott Laboratories	134.92	234.01B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	104.49	154.20B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	382.78	146.06B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	89.94	115.42B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.30	43.23B	5.72B	4.17B	490.10M	6.97

Standard Biotools Inc Stock (LAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-16-24	Initiated	TD Cowen	Buy
Apr-04-24	Initiated	Jefferies	Buy
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight

Standard Biotools Inc Stock (LAB) Latest News

Feb 21, 2025

Market Cool On Standard BioTools Inc.'s (NASDAQ:LAB) Revenues Pushing Shares 28% Lower - Simply Wall St

Feb 21, 2025

Feb 20, 2025

Standard BioTools (LAB) to Release Earnings on Wednesday - MarketBeat

Feb 20, 2025

Feb 18, 2025

Standard BioTools (NASDAQ:LAB) Stock Price Up 7.1%Here's What Happened - MarketBeat

Feb 18, 2025

Feb 16, 2025

Sumitomo Mitsui Trust Group Inc. Sells 2,960,169 Shares of Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat

Feb 16, 2025

Feb 15, 2025

Standard BioTools (NASDAQ:LAB) Hits New 52-Week LowTime to Sell? - MarketBeat

Feb 15, 2025

Feb 14, 2025

Taking a look at what insiders are doing to gauge the Standard BioTools Inc (LAB)’s direction - Knox Daily

Feb 14, 2025

Feb 13, 2025

Fluidigm stock hits 52-week low at $1.21 amid market challenges - MSN

Feb 13, 2025

Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 - GlobeNewswire

Feb 13, 2025

Feb 12, 2025

Standard BioTools Sets Date for Crucial Year-End Financial Results Reveal - StockTitan

Feb 12, 2025

Feb 10, 2025